NON-FINAL ACTION - MAILED
final action
on 15 Nov 2024
Last Applicant/ Owned by
Babraham Research Campus
Babraham, Cambridge
GB
CB223AT
Serial Number
98529048 filed on 01st May 2024
Registration Number
N/A
Correspondent Address
Patricia I. Reding
Patricia I. Reding Faegre Drinker Biddle & Reath LLP
2200 Wells Fargo Center
Minneapolis, MN 55402
United States
Filing Basis
1. filed as use application
2. use application currently
Disclaimer
NO DATA
THIOBRIDGE
Pharmaceutical research services; pharmaceutical product evaluation; inspection of pharmaceuticals; testing of pharmaceuticals; pharmaceutical drug development services; development of pharmaceutical preparations and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; provision of scientific information; compilation and provision of Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Pharmaceutical research services; pharmaceutical product evaluation; inspection of pharmaceuticals; testing of pharmaceuticals; pharmaceutical drug development services; development of pharmaceutical preparations and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; provision of scientific information; compilation and provision of toxicological information; assessing toxicological information in relation to risks; assessing chemical information in relation to risks; provision of scientific information relating to the chemical industry
First Use Date in General
23rd Jul 2014
First Use Date in Commerce
23rd Jul 2014
Class [005]
Pharmaceutical Products
Pharmaceutical preparations and substances for the treatment of viral diseases and disorders, neurological diseases and disorders, immune diseases and disorders, respiratory diseases and disorders, microbial infections and diseases, cancer, haematological diseases and disorders, gastro-intestinal diseases and disorders, inflammation, arthritis, hepatitis, anemia, coagulation diseases and disorders, pain, obesity, and diabetes; chemical preparations for medical use, namely, peptide and protein agents; diagnostic reagents for medical use
First Use Date in General
23rd Jul 2014
First Use Date in Commerce
23rd Jul 2014
Class [001]
Chemical Products
Chemical preparations for use as pharmaceutical intermediates; chemical preparations for use in the manufacture of pharmaceuticals; diagnostic reagents for scientific use; reagents for scientific purposes
First Use Date in General
23rd Jul 2014
First Use Date in Commerce
23rd Jul 2014
Mark Details
Serial Number
No 98529048
Mark Type
No Service Mark
Attorney Docket Number
No 531360.1
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 15th Nov 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 15th Nov 2024 | ASSIGNED TO EXAMINER |
| 15th Nov 2024 | NON-FINAL ACTION E-MAILED |
| 15th Nov 2024 | NON-FINAL ACTION WRITTEN |
| 27th Oct 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| 01st May 2024 | NEW APPLICATION ENTERED |